Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
NICCA CHEMICAL, 5% Increase in Ordinary Profit, Record High for The First Time in Two Years, Dividend Raised by 10 Yen
4463 NICCA CHEMICAL CO.,LTD. 【J-GAAP】
Earnings ReportNICCA CHEMICAL CO.,LTD. <4463> [TSE Std] announced its financial results in the afternoon session on February 13th (15:00). The consolidated ordinary profit for the fiscal year ended December 2025 decreased by 3.2% from the previous period to 3.84 billion yen. For the fiscal year ending December 2026, the consolidated ordinary profit is expected to grow by 5.2% to 4.05 billion yenExpected to reach record high profits for the first time in two years. This will be the third consecutive term of revenue growth.
At the same time, the company has decided to increase the dividend this fiscal year to 70 yen, an increase of 10 yen from the previous fiscal year.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit decreased to 1.09 billion yen, a 4.1% decrease compared to the same period last year. The operating profit margin worsened from 6.9% in the same period last year to 6.5%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 50,169 | 2,039 | 2,528 | 1,691 | 107.1 | 32 | Feb 13, 2024 | J-GAAP |
| Dec, 2024 | 54,099 | 3,519 | 3,976 | 2,754 | 174.2 | 52 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 | 55,705 | 3,847 | 3,849 | 2,384 | 150.3 | 60 | Feb 13, 2026 | J-GAAP |
| YoY | +3.0% | +9.3% | -3.2% | -13.4% | -13.7% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2025 Guidance | 57,000 | 3,600 | 3,400 | 2,400 | 150.8 | 60 | Jul 31, 2025 | J-GAAP |
| Dec, 2025 Results | 55,705 | 3,847 | 3,849 | 2,384 | 150.3 | 60 | Feb 13, 2026 | J-GAAP |
| Revision Rate | -2.3% | +6.9% | +13.2% | -0.7% | -0.3% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 | 27,180 | 1,935 | 1,752 | 997 | 62.9 | 30 | Jul 31, 2025 | J-GAAP |
| Jan - Jun, 2026 Guidance | ー | ー | ー | ー | - | 35 | Feb 13, 2026 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2024 | 54,099 | 3,519 | 3,976 | 2,754 | 174.2 | 52 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 | 55,705 | 3,847 | 3,849 | 2,384 | 150.3 | 60 | Feb 13, 2026 | J-GAAP |
| Dec, 2026 Guidance | 58,500 | 4,200 | 4,050 | 2,800 | 175.9 | 70 | Feb 13, 2026 | J-GAAP |
| YoY | +5.0% | +9.2% | +5.2% | +17.4% | +17.1% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 14,623 | 1,011 | 1,137 | 906 | 57.3 | 6.9 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 13,195 | 856 | 804 | 292 | 18.5 | 6.5 | May 1, 2025 | J-GAAP |
| Apr - Jun, 2025 | 13,985 | 1,079 | 948 | 705 | 44.5 | 7.7 | Jul 31, 2025 | J-GAAP |
| Jul - Sep, 2025 | 14,037 | 966 | 1,007 | 616 | 38.9 | 6.9 | Oct 31, 2025 | J-GAAP |
| Oct - Dec, 2025 | 14,488 | 946 | 1,090 | 771 | 48.6 | 6.5 | Feb 13, 2026 | J-GAAP |
| YoY | -0.9% | -6.4% | -4.1% | -14.9% | -15.2% |
Related Articles
SUNNY SIDE UP, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 18%, Raises Record High Profit Forecast, Dividend Revised Upward by 2 Yen
Cyfuse Biomedical, The Current Fiscal Year's Net Income to Widen
SHOBIDO, Oct-Dec (1Q) Ordinary Profit Increases by 2.0 times
Semba Tohka Industries, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 6%, Oct-Dec Ordinary Profit Increases by 68%
MITANI SEKISAN, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 27%, Oct-Dec Ordinary Profit Increases by 28%
NICHIREKI , Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 16%, Oct-Dec Ordinary Profit Decreases by 20%
ONOKEN, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 38%, Oct-Dec Ordinary Profit Decreases by 10%
TPR, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 11%
FUTABA, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Decreases by 63%
JINJIB, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Loss Widens